While others played safe, Shanghvi bet on complex generics and specialty pharma, and rode a wave of acquisitions to make Sun ...

In the latest episode of Inside Forbes India Podcast, Naini Thaker discusses her deep-dive profile on Dilip Shanghvi, the low ...

Ambani emerged as the biggest gainer during this period, with his net worth surging by nearly $20 billion from a March low of ...

Drugmakers breathed a sigh of relief Wednesday after President Trump didn’t announce pharmaceutical tariffs. Plus, language in the executive order indicated medicines were exempted from the ...

Sun Pharmaceutical, India’s largest drugmaker, derived 32% of its revenue from the U.S. in 2024, with managing director Dilip Shanghvi acknowledging that the added costs would likely be passed ...

Sun Pharmaceutical Industries Ltd. 524715 shares rallied 1.04% to 1,705.15 Indian rupees Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the BSE ...

including Dilip Shanghvi - founder of Sun Pharma. Shanghvi has lost $3.34 billion with the pharmaceutical sector facing strong competition and regulatory pressures, which has led to Sun Pharma stock ...

In line with this, Dilip Shanghvi, the founder of Sun Pharma, has seen his wealth decline by $3.34 billion this year. The pharmaceutical sector has faced regulatory pressures and intense competition, ...

The net worth of Mukesh Ambani, Gautam Adani, Shiv Nadar, and others has taken a massive hit amid a sharp correction in ...

Credit: Getty Sun Pharma’s Dilip Shanghvi has lost $3.34 billion, as Sun Pharma’s shares sank nearly 11% this year. 7 things to know about Ather Energy IPO 7 busiest airports in the world by passenger ...

NEW DELHI: Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.